The proposed chemical class of ITI-H3 Activators encompasses a broad range of compounds that can influence various cellular signaling pathways and processes. These chemicals do not directly activate ITI-H3 but could modulate its activity by affecting the cellular environment in which ITI-H3 operates. Compounds like Forskolin and Ionomycin are known to increase levels of secondary messengers (cAMP and calcium, respectively), which are pivotal in many cellular functions. PMA, by activating PKC, could influence a wide array of proteins and pathways. Similarly, LY294002 and PD98059, by targeting PI3K and MEK, respectively, can indirectly modulate the activity of proteins involved in these signaling cascades.
Inhibitors like Rapamycin, U0126, and SB203580, which target mTOR, MEK, and p38 MAPK respectively, demonstrate the possibility of indirectly influencing protein activities through the inhibition of key signaling molecules. BAPTA-AM and NF-κB Activation Inhibitor also exemplify how altering intracellular calcium levels or NF-κB activity can impact various cellular processes. Dexamethasone, a widely known glucocorticoid, can affect numerous pathways, indicating the broad spectrum of indirect effects these chemicals can have. The ITI-H3 Activators class represents a collection of chemical agents capable of modulating diverse signaling pathways that could indirectly influence the function of ITI-H3, assuming its involvement in such pathways. This speculative class underscores the complexity and interconnected nature of cellular signaling and its impact on protein function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylyl cyclase, potentially increasing cAMP, which is a common secondary messenger in many signaling pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C (PKC), which is involved in various signaling pathways. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $94.00 $259.00 | 2 | |
Increases intracellular calcium, a key secondary messenger in numerous signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor, can indirectly affect signaling pathways by altering PI3K activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK, potentially affecting MAPK/ERK pathway signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor, influencing the p38 MAPK signaling pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, affecting the mTOR signaling pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
A MEK inhibitor, could affect various signaling pathways through MEK inhibition. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, potentially altering JNK signaling pathways. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
A calcium chelator, can modulate calcium-mediated signaling pathways. | ||||||